Promoter orientation within an AAV-CRISPR vector affects Cas9 expression and gene editing efficiency

Míreanna comhchosúla

• RNA editing for Usher syndrome using CRISPR-Cas13
  de réir: Fry, LE, et al.
  Foilsithe / Cruthaithe: (2020)
• RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences
  de réir: Fry, LE, et al.
  Foilsithe / Cruthaithe: (2020)
• Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes
  de réir: McClements, M, et al.
  Foilsithe / Cruthaithe: (2017)
• Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
  de réir: Fry, LE, et al.
  Foilsithe / Cruthaithe: (2025)
• Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant
  de réir: Bellingrath, J-S, et al.
  Foilsithe / Cruthaithe: (2022)